TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
66.87
66.87
Rango anual
23.30
69.20
Cambio diario
-3.13%
Variación mensual
+16.30%
Variación en los últimos 6 meses
+114.05%
Cambio anual
+133.73%
Cierres anteriores
69.0 3
Open
66.8 7
Mínimo
66.8 7
High
66.8 7
Volumen
165
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Noticias